Product Details

** Dental offices are responsible for obtaining the CLIA Certificate of Waiver. Offices should consult the appropriate governmental agency with any questions. Benco Dental will not be liable for a customer not having a CLIA Certificate of Waiver or if any forms are not properly completed. ** 25 tests per kit FDA Emergency Use Authorization Rx ONLY ** There will be no returns allowed on this product and there will be no cancellations once ordered from Benco Dental ** The QuickVue SARS Antigen Test detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments. PPA (Reference Extracted SARS-CoV-2 RT-PCR Assay) 96.6% / NPA Reference Extracted SARS-CoV-2 RT-PCR Assay) 99.3% Feature Benefit Dipstick test format Simple workflow follows a similar format to CLIA-waived QuickVue assays. No instrument necessary. Results in 10 minutes Test and treat in the same office visit. Two-color result Easy to read and interpret. Blue control line and red test line. All components included in kit Ready to use, no need for additional equipment. Room temperature storage No refrigerator space needed. No need to wait for reagents to warm up. Rapid SARS-CoV-2 tests can be run immediately as needed. The QuickVue SARS Antigen Test has not been FDA cleared or approved, but has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner.